Journal of the American Heart Association

Long COVID Risks for Heart, Kidney, and Lung Problems Vary by Age and Sex

Long Covid Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

Individuals with Long COVID may be at increased risk for adverse cardiovascular, renal, and pulmonary outcomes.

  • A substantial number of patients with acute COVID-19 experience Long COVID.
  • The exact risk of cardiovascular and related complications in Long COVID patients is not well understood.
  • There is a hypothesis that Long COVID may lead to higher risks of adverse cardiovascular, renal, and pulmonary outcomes compared to those who fully recover from COVID-19.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Featured in

Long CovidLong CovidIssue #51
Your gut bacteria during COVID infection may predict whether you develop long COVID
↗

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the long covid brief

issue #51
Your gut bacteria during COVID infection may predict whether you develop long COVID
today7 studies
issue #50
A probiotic just beat placebo for long COVID fatigue in a randomized trial
1 week ago7 studies
issue #49
Dormant viruses wake up during COVID — and some are still active in long COVID patients
2 weeks ago7 studies
issue #48
A drug combo for post-COVID heart inflammation just ran a full trial. The primary endpoint didn't move.
3 weeks ago7 studies
issue #47
Women with long COVID face more severe neurological symptoms than men, new data shows
4 weeks ago7 studies
issue #46
Paxlovid didn't prevent long COVID in a randomized trial. Now what?
5 weeks ago7 studies
issue #45
A UK trial tested three repurposed drugs for long COVID fatigue. Here's what happened.
6 weeks ago7 studies
issue #44
A randomized trial tested cognitive rehab for long COVID brain fog — here's what happened
7 weeks ago7 studies
issue #43
An Alzheimer's drug may ease fatigue and depression in ~63% of long COVID patients with a reactivated herpesvirus
8 weeks ago7 studies
issue #42
81% of long COVID patients with dizziness on standing may have central sensitization
9 weeks ago7 studies
explore the archive
See more issues from the long covid brief